Apply to the Academic Clinical Trials Program Thumbnail Image Read more about Apply to the Academic Clinical Trials Program
Academic Clinical Trials Program (ACT) Thumbnail Image Read more about Academic Clinical Trials Program (ACT)
Yescarta® Receives U.S. FDA Approval as First CAR T-cell Therapy for Initial Treatment of Relapsed or Refractory Large B-cell Lymphoma (LBCL) Thumbnail Image Read more about Yescarta® Receives U.S. FDA Approval as First CAR T-cell Therapy for Initial Treatment of Relapsed or Refractory Large B-cell Lymphoma (LBCL)
Faron Pharmaceuticals Announces the Private Placement of EUR 5 Million, Including LLS TAP Thumbnail Image Read more about Faron Pharmaceuticals Announces the Private Placement of EUR 5 Million, Including LLS TAP
Kymera Therapeutics Doses First Patients in Phase 1 Oncology Trials of STAT3 and IRAKIMiD Degraders KT-333 and KT-413 Thumbnail Image Read more about Kymera Therapeutics Doses First Patients in Phase 1 Oncology Trials of STAT3 and IRAKIMiD Degraders KT-333 and KT-413
ImCheck Closes Upsized EUR 96 Million (USD 103 Million) Financing to Advance Clinical Program of First-in-human Gamma-delta T Cell Activating Antibody and Accelerate Development of Disruptive Immunotherapeutic Pipeline Thumbnail Image Read more about ImCheck Closes Upsized EUR 96 Million (USD 103 Million) Financing to Advance Clinical Program of First-in-human Gamma-delta T Cell Activating Antibody and Accelerate Development of Disruptive Immunotherapeutic Pipeline
Caribou Biosciences Reports Positive Additional Data from CB-010 Allogeneic CAR-T Cell Therapy Phase 1 ANTLER Trial at the European Hematology Association (EHA) 2022 Hybrid Congress Thumbnail Image Read more about Caribou Biosciences Reports Positive Additional Data from CB-010 Allogeneic CAR-T Cell Therapy Phase 1 ANTLER Trial at the European Hematology Association (EHA) 2022 Hybrid Congress
Ryvu Therapeutics Presents Updated Clinical and Preclinical Data on RVU120 at the 2022 European Hematology Association (EHA) Congress Thumbnail Image Read more about Ryvu Therapeutics Presents Updated Clinical and Preclinical Data on RVU120 at the 2022 European Hematology Association (EHA) Congress
Jazz Pharmaceuticals to Present Data Showcasing Clinical Advancements Across Oncology Portfolio at 2022 EHA Meeting Thumbnail Image Read more about Jazz Pharmaceuticals to Present Data Showcasing Clinical Advancements Across Oncology Portfolio at 2022 EHA Meeting
MorphoSys to Present New Data on Pelabresib at the 2022 European Hematology Association (EHA) Thumbnail Image Read more about MorphoSys to Present New Data on Pelabresib at the 2022 European Hematology Association (EHA)